# A Study of the Efficacy and Safety of Tocilizumab for Confirmed Rheumatoid Arthritis (RA) Participants in Clinical Practice

> **NCT02616328** · — · TERMINATED · sponsor: **Hoffmann-La Roche** · enrollment: 8 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT02616328
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-26
- **Primary completion:** 2017-12-12
- **Final completion:** 2017-12-12
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Planned recruitment target not reached
- **Last updated:** 2018-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02616328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02616328, "A Study of the Efficacy and Safety of Tocilizumab for Confirmed Rheumatoid Arthritis (RA) Participants in Clinical Practice". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02616328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*